Triton 1 System
NEPTUNE MEDICAL INC. · Decision date Sep 3, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K260503, the Triton 1 System from Neptune Medical, Inc., on September 3, 2026, under 21 CFR 876.1500 as a Class II colonoscope and accessories device with product codes FDF, FED and FET. The submission was received February 17, 2026, and reviewed as a traditional 510(k) without third-party review. A SESE decision is a clearance, not a PMA approval.
The cleared device is described as a user-operated, electromechanically controlled rigidizing endoscope nested within a rigidizing overtube, both advanced and retracted independently under physician control, with selective rigidization to hold shape in the lower GI tract. The primary predicate listed is the NeoGuide Endoscopy System (K070622), with the Pathfinder Endoscope Overtube (K211301) and an Olympus vision system (K100584) as references. The summary states that technological differences raise no new safety or effectiveness questions; clinical outcome data are not summarized in the available excerpts.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 3, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260503
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- NEPTUNE MEDICAL INC.
- Product code
- FDF
- Decision code
- SESE
- Decision date
- Sep 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Colonoscope And Accessories, Flexible/Rigid.
- Applicant
- NEPTUNE MEDICAL INC.
- Product code
- FDF
- FDA device class
- 2
FDA decision timeline
K260503 received
Application receipt date recorded by FDA.
K260503 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
NEPTUNE MEDICAL INC.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Burlingame, CA
Sources and methodology
- Original FDA record: K260503
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records